| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
endosulfine alpha | 0.760 | 0.308 | 0.35 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||
|
melanocyte inducing transcription factor | 0.499 | 0.808 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
MYC target 1 | 0.792 | 0.308 | 3.7E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
cation channel sperm associated 2 pseudogene 1 | 0.931 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like | 6.9E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||||
|
PALM2 and AKAP2 fusion | 0.751 | 0.385 | 6.1E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
methionine sulfoxide reductase A | 0.608 | 0.615 | 1.5E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
gametogenetin binding protein 1 (pseudogene) | 0.769 | 0.462 | 0.69 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
MAX interactor 1, dimerization protein | 0.547 | 0.615 | 1.1E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
MYB proto-oncogene, transcription factor | 0.490 | 0.692 | 0.82 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
myosin IC | 0.700 | 0.423 | 1.6E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
activating transcription factor 3 | 0.494 | 0.885 | 8.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
nucleosome assembly protein 1 like 4 | 0.861 | 0.231 | 0.77 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
NBL1, DAN family BMP antagonist | 0.670 | 0.500 | 5.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
MIA SH3 domain ER export factor 2 | 0.700 | 0.577 | 1.0E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
mitogen-activated protein kinase kinase kinase 5 | 0.513 | 0.808 | 0.52 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
testis expressed 41 | 0.743 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2019 | 2019 | |||||||||
|
death domain containing 1 | 1.000 | 0.077 | 3.4E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
patatin like phospholipase domain containing 3 | 0.556 | 0.692 | 5.7E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
long intergenic non-protein coding RNA 336 | 0.861 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1624 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||||
|
VLDLR antisense RNA 1 | 0.821 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
centromere protein P | 1.000 | 0.077 | 4.6E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
aryl hydrocarbon receptor nuclear translocator | 0.575 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 |